Stereotactic Body Radiotherapy for Hepatocellular Carcinoma: Meta-analysis and International Stereotactic Radiosurgery Society Practice Guidelines |
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Certificate of Attendance
|
Journal Activities |
01/12/2024 to 01/11/2026 |
$49.00 |
Partial Breast Irradiation for Patients With Early-Stage Invasive Breast Cancer or Ductal Carcinoma In Situ: An ASTRO Clinical Practice Guideline |
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Certificate of Attendance
|
Journal Activities |
02/29/2024 to 02/28/2026 |
$49.00 |
Radiotherapy in Alzheimer's Disease: A Systematic Review |
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Certificate of Attendance
|
Journal Activities |
04/15/2024 to 04/14/2026 |
$49.00 |
Immunotherapy and Radiation Therapy Sequencing in Breast Cancer: A Systematic Review |
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Certificate of Attendance
|
Journal Activities |
03/14/2024 to 03/13/2026 |
$49.00 |
Gray Zone - A Tough Question to Swallow: Role of Radiation Therapy in Rapidly Progressive Mediastinal Sarcoma |
- 1.00 AMA PRA Category 1 Credit™
|
Journal Activities |
06/24/2024 to 06/23/2025 |
$0.00 |
Gray Zone - Put Your Best Smile Forward: Rhabdomyosarcoma of the Parotid Gland |
- 1.00 AMA PRA Category 1 Credit™
|
Journal Activities |
12/12/2024 to 12/11/2025 |
$0.00 |
Gray Zone - Conebeam CT Scan Reveals a Space Invader: Fire All Beams or Fall Back? |
- 1.00 AMA PRA Category 1 Credit™
|
Journal Activities |
06/06/2025 to 06/05/2026 |
$0.00 |
Gray Zone - A Rare Cancer Arising in an Uncommon Site: Treatment of Adenoid Cystic Carcinoma of the Trachea |
- 1.00 AMA PRA Category 1 Credit™
|
Journal Activities |
07/17/2024 to 07/16/2025 |
$0.00 |
Gray Zone - Which Way to (INDI)GO? |
- 1.00 AMA PRA Category 1 Credit™
|
Journal Activities |
05/15/2025 to 05/14/2026 |
$0.00 |
Gray Zone - Beyond the Blade: Retropharyngeal Lymph Nodes and an Elusive Complete Resection |
- 1.00 AMA PRA Category 1 Credit™
|
Journal Activities |
08/08/2024 to 08/07/2025 |
$0.00 |
Gray Zone - A Blast from the Past: Definitive Management of Favorable Early Stage Hodgkin Lymphoma Ineligible for Systemic Therapy |
- 1.00 AMA PRA Category 1 Credit™
|
Journal Activities |
04/14/2025 to 04/13/2026 |
$0.00 |
2025 Quarter 2 - Journal Reviewer CME |
- 3.00 AMA PRA Category 1 Credit™
|
Journal Activities |
04/01/2025 to 07/31/2025 |
$0.00 |
Gray Zone - Boosting the Odds: Navigating Fraction Options in the DCIS Odyssey |
- 1.00 AMA PRA Category 1 Credit™
|
Journal Activities |
09/05/2024 to 09/04/2025 |
$0.00 |
Gray Zone - Unresectable Pancreatic Adenocarcinoma: Evidence-Based Medicine or a Gut Feeling? |
- 1.00 AMA PRA Category 1 Credit™
|
Journal Activities |
03/13/2025 to 03/12/2026 |
$0.00 |
Gray Zone - Mind Over Matter: Complete Craniospinal Irradiation or Just Treat the Spine |
- 1.00 AMA PRA Category 1 Credit™
|
Journal Activities |
02/21/2025 to 02/20/2026 |
$0.00 |